Telos Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Buy |
+482
| New | +$253K | 0.03% | 182 |
|
|
2025
Q1 | – | Sell |
-301
| Closed | -$214K | – | 201 |
|
|
2024
Q4 | $214K | Sell |
301
-41
| -12% | -$29.2K | 0.02% | 190 |
|
|
2024
Q3 | $360K | Hold |
342
| – | – | 0.04% | 163 |
|
|
2024
Q2 | $359K | Sell |
342
-1
| -0.3% | -$1.05K | 0.04% | 160 |
|
|
2024
Q1 | $330K | Sell |
343
-1
| -0.3% | -$962 | 0.04% | 164 |
|
|
2023
Q4 | $302K | Sell |
344
-11
| -3% | -$9.66K | 0.04% | 172 |
|
|
2023
Q3 | $292K | Sell |
355
-17
| -5% | -$14K | 0.04% | 157 |
|
|
2023
Q2 | $267K | Sell |
372
-7
| -2% | -$5.03K | 0.04% | 173 |
|
|
2023
Q1 | $311K | Sell |
379
-41
| -10% | -$33.7K | 0.04% | 157 |
|
|
2022
Q4 | $303K | Buy |
420
+96
| +30% | +$69.3K | 0.04% | 159 |
|
|
2022
Q3 | $223K | Buy |
+324
| New | +$223K | 0.04% | 159 |
|
|
2022
Q2 | – | Sell |
-333
| Closed | -$233K | – | 184 |
|
|
2022
Q1 | $233K | Buy |
333
+3
| +0.9% | +$2.1K | 0.03% | 168 |
|
|
2021
Q4 | $208K | Sell |
330
-2
| -0.6% | -$1.26K | 0.03% | 184 |
|
|
2021
Q3 | $201K | Buy |
+332
| New | +$201K | 0.03% | 178 |
|